David Komander

31.9k citations
139 papers · 26.3k · 12 hit papers · h-index 73

Impact in

    • Ubiquitin and proteasome pathways
    • PI3K/AKT/mTOR signaling in cancer
    • Cell death mechanisms and regulation
    • Protein Kinase Regulation and GTPase Signaling
    • NF-κB Signaling Pathways

Papers in

    • Ubiquitin and proteasome pathways 93
    • PI3K/AKT/mTOR signaling in cancer 11
    • Protein Kinase Regulation and GTPase Signaling 11
    • NF-κB Signaling Pathways 14

David Komander

138 papers receiving 25.8k citations

David Komander's Hit Papers

A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID 2025 · 21 citations
210+5+11Years since publication5001k1.5k2k2.5k

Peers

David Komander
Comparison fields: 5 of 124
  • Molecular Biology 18k
  • Cancer Research 2.2k
  • Immunology 1.6k
  • Neurology 1.1k
  • Epidemiology 1.9k
Replace She Chen with:
She Chen China
Brenda Arlene Schulman United States
Matthias Selbach Germany
Nancy Kedersha United States
Michael Cory Bassik United States
Jerry Pelletier Canada
Paul Anderson United States
J. Marie Hardwick United States
Cecile M. Pickart United States
Wim Declercq Belgium
David Komander relative to She Chen China She Chen's profile →
Citations per field
00.5×2×2.6×
She Chen · 1×
Citations per year

Countries citing papers authored by David Komander

Since Specialization
Citations

This map shows the geographic impact of David Komander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Komander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Komander more than expected).

Fields of papers citing papers by David Komander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Komander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Komander. The network helps show where David Komander may publish in the future.

Co-authors

The 25 scholars most cited alongside David Komander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Komander Line = papers co-authored together David Komander links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The Ubiquitin Code
Hit paper breakdown →
20122971
2
Breaking the chains: structure and function of the deubiquitinases
Hit paper breakdown →
20091773
3
Ubiquitin modifications
Hit paper breakdown →
20161669
4
The nuts and bolts of AGC protein kinases
Hit paper breakdown →
20091066
5
Mechanisms of Deubiquitinase Specificity and Regulation
Hit paper breakdown →
2017838
6 2004671
7
Breaking the chains: deubiquitylating enzyme specificity begets function
Hit paper breakdown →
2019667
8 2009658
9
The emerging complexity of protein ubiquitination
Hit paper breakdown →
2009657
10 2009630
11 2012562
12 2013505
13 2009484
14 2001416
15 2020405
16 2013403
17
Mechanism of phospho-ubiquitin-induced PARKIN activation
Hit paper breakdown →
2015402
18 2013380
19 2017377
20 2018323

About David Komander

David Komander is a scholar working on Molecular Biology, Cancer Research, Neurology, Immunology and Infectious Diseases, having authored 139 papers that have together received 26.3k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (93 papers), NF-κB Signaling Pathways (14 papers), PI3K/AKT/mTOR signaling in cancer (11 papers), Protein Kinase Regulation and GTPase Signaling (11 papers), Parkinson's Disease Mechanisms and Treatments (10 papers), Autophagy in Disease and Therapy (6 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and interferon and immune responses (3 papers). The work is most often cited by research in Molecular Biology (18k citations), Cancer Research (2.2k citations), Immunology (1.6k citations), Neurology (1.1k citations) and Epidemiology (1.9k citations). David Komander has collaborated with scholars based in United Kingdom, Australia and Germany. Frequent co-authors include Michael Rapé, Kirby N. Swatek, Michael J. Clague, Sylvie Urbé, Tycho E.T. Mevissen, Dario R. Alessi, Yogesh Kulathu, Tobias Wauer, Laura R. Pearce and Daan M. F. van Aalten. Their work appears in journals such as Molecular Cell, The EMBO Journal, Nature, Nature Structural & Molecular Biology and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact